AR SR3

Proclaims February 24, 2023, as "SCN2A Day" in Arkansas to recognize the impact of SCN2A on families and increase public awareness.

SCN2A is a gene located on chromosome 2 that produces a sodium channel in nerve cells; mutations cause excessive sodium entry leading to increased electrical activity and epilepsy.

SCN2A variants are linked to benign familial neonatal infantile seizures (BFNIS), infantile spasms, Dravet Syndrome, Ohtahara Syndrome, West Syndrome, and early infantile epileptic encephalopathies.

SCN2A variants are also associated with intellectual disability, schizophrenia, autism, sleep problems, cerebral palsy, and movement disorders.

While no cure currently exists, ongoing research is developing genetic approaches to correct the genetic abnormality and new drugs to treat SCN2A; genetic testing can diagnose SCN2A mutations.